Le Lézard
Classified in: Health, Science and technology, Business
Subjects: NPT, PDT, LIC

UMass Memorial Health Integrates LanguageLine App into Epic EHR


Implementation increases operational efficiency, accuracy, and compliance with on-demand interpretation capabilities to support caregiver and patient experience

WORCESTER, Mass., Feb. 21, 2024 /PRNewswire/ -- UMass Memorial Health (UMMH), the largest not-for-profit health system in Central Massachusetts, has become first health system to integrate the LanguageLine Solutions interpreting app into its Epic Electronic Health Record (EHR).

Particularly useful for clinicians who care for limited English speakers, as well as patients who are Deaf or Hard of Hearing, the LanguageLine app provides on-demand access to a network of 20,000 medical interpreters ? more than 240 languages. The tool is embedded directly in the Epic charting application used broadly for patient appointments, streamlining processes and enhancing care for diverse populations in UMMH's areas of service.

In 2023, UMMH patients spoke 108 different languages, leading to over six million minutes of interpretation. LanguageLine Solutions' app simplifies the process of connecting with an interpreter and ensures automated, accurate data collection for billing, compliance audits, and reimbursement opportunities, allowing clinicians to focus solely on the patient's care plan and outcomes.

Integrating into Epic allows sessions to be encrypted and documented in the EHR, delivering a timely, accurate record of the patient's interpretation history. For UMMH, LanguageLine developed a flexible method, allowing the health system's technology team to configure and make changes to the integration on their own.

"We are pleased to offer this new resource to help create a better care experience for our patients, while improving efficiencies for our clinical teams," said Dr. Eric Alper, Chief Quality Officer and Chief Clinical Informatics Officer at UMMH. "Advancements in this area support our mission to improve health equity through our technological capabilities and the care we provide to our communities."

A single click from Epic's Haiku, Canto or Rover app automatically launches LanguageLine's app with the patient's information and preferred language already selected. Connecting with a LanguageLine interpreter typically takes less than 15 seconds. Video and audio-only formats are offered, and no appointment is required. The service is available 24 hours a day, seven days a week.

"The Epic integration is a testament to the power of partnership," LanguageLine President and CEO Scott W. Klein said. "Not only was it a close collaboration between the UMMH technology team and ours, but we spent considerable time interviewing doctors, nurses, and other clinical staff to better understand the workflow involved in serving patients who speak limited English, or who are Deaf or Hard of Hearing."

After an interpretation session is complete, LanguageLine writes back key data including language requested, call duration, and interpreter identification to clinic notes, flow sheets, and other data storage locations in Epic?automating a process that clinicians had previously complete manually. Building this interpreter-session history into a patient's record helps providers ensure compliance with regulations outlined in Section 1557 of the Patient Protection and Affordable Care Act.

The LanguageLine app uses the secure healthcare standard SMART on FHIR that ensures patient safety and organizational compliance.

To learn more about LanguageLine for EHR, please visit https://www.languageline.com/interpreting/on-demand/ehr.

About LanguageLine
LanguageLine is the world's foremost provider of on-demand interpretation and translation services, with a team of more than 30,000 professional linguists. Thousands of healthcare organizations ? including 18 of North America's top 20 hospital systems ? currently use LanguageLine for on-demand interpretation. Now LanguageLine is leading the digital transformation of partnerships between the language access and healthcare industries.

About UMass Memorial Health
UMass Memorial Health is the largest not-for-profit health care system in Central Massachusetts with 17,000 employees and 2,100 physicians. Our comprehensive system includes UMass Memorial Medical Center, UMass Memorial Health ? Harrington, UMass Memorial Health ? HealthAlliance-Clinton Hospital, UMass Memorial Health ? Marlborough Hospital, UMass Memorial Health ? Community Healthlink, and UMass Memorial Medical Group. We are the clinical partner of UMass Chan Medical School. For more information, visit www.ummhealth.org.

Media Contact:
Scott Brown
[email protected]
831-224-3187

SOURCE LanguageLine Solutions


These press releases may also interest you

at 04:00
King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have...

at 04:00
IFPA (The International Federation of Psoriasis Associations) concluded its highly anticipated 7th IFPA Conference on World Psoriasis and Psoriatic Arthritis, held from June 27 to 29, 2024, in Stockholm, Sweden. Established in 2006, the conference...

at 03:43
IASO biotechnology ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody products, presented the clinical data and single-cell analysis of the fully human...

at 03:37
RaySearch Laboratories AB (publ) announces the launch of RayStation®* 2024B, the latest version of the company's innovative treatment planning system. The new version comes with automation of important clinical workflows, such as automatic image...

at 03:15
TauRx Pharmaceuticals Ltd, a global leader in tau-based research in Alzheimer's disease (AD), has announced the submission of a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) for treatment of mild cognitive...

at 03:00
Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunoglobulin therapy Yimmugo® in the U.S., following its...



News published on and distributed by: